Overview
For patients with early-stage lung cancer, surgery offers the best chance of cure — and the quality of that surgery matters enormously. Precision minimally invasive techniques, careful patient selection, and expert surgical judgment determine not only whether the cancer is cured, but also how quickly the patient recovers and what quality of life they enjoy afterward. Shanghai is home to China's leading early-stage lung cancer surgical program, led by a specialist whose reputation for precision minimally invasive surgery is unmatched in the field.
China Medical Concierge Shanghai (CMCS) connects international patients with Shanghai's top lung cancer surgeons, providing end-to-end support from remote consultation through to post-treatment follow-up.
Understanding Early-Stage Lung Cancer
What Is Early-Stage Lung Cancer?
Early-stage lung cancer (stage I and II) refers to disease that is confined to the lung, without spread to distant lymph nodes or other organs. With the widespread adoption of low-dose CT (LDCT) screening, an increasing proportion of lung cancers are now detected at an early, potentially curable stage — often as small pulmonary nodules or ground-glass opacities (GGOs) on CT scan.
The most common type of early-stage lung cancer is lung adenocarcinoma, which frequently presents as a GGO or part-solid nodule on CT. Accurate characterization of these lesions — distinguishing benign from malignant nodules, and identifying which malignant nodules require immediate surgery versus active surveillance — requires specialized expertise.
Common Presentations
- Incidental pulmonary nodule found on CT scan (often asymptomatic)
- Ground-glass opacity (GGO) or part-solid nodule on LDCT screening
- Persistent cough or mild chest discomfort
- Haemoptysis (coughing up blood)
Risk Factors
- Smoking (the leading cause)
- Secondhand smoke exposure
- Radon gas exposure
- Occupational exposures (asbestos, arsenic)
- Air pollution
- Family history of lung cancer
- Prior lung disease (COPD, pulmonary fibrosis)
Diagnosis & Staging for Early-Stage Lung Cancer
- Low-dose CT (LDCT) — the gold standard for lung cancer screening and nodule characterization
- High-resolution CT (HRCT) — detailed characterization of pulmonary nodules and GGOs
- PET-CT — staging and detection of occult nodal or distant metastasis
- Brain MRI — brain metastasis assessment for stage II disease
- CT-guided biopsy or bronchoscopy — tissue diagnosis when needed
- Molecular profiling — EGFR, ALK, ROS1, and other driver mutations — essential for adjuvant therapy planning after surgery
Treatment: Precision Minimally Invasive Surgery
Video-Assisted Thoracoscopic Surgery (VATS)
VATS (video-assisted thoracoscopic surgery) is the standard minimally invasive approach for early-stage lung cancer resection. Using small incisions and a thoracoscopic camera, VATS lobectomy and segmentectomy achieve equivalent oncological outcomes to open surgery with significantly less pain, shorter hospital stay, faster recovery, and lower complication rates.
Sublobar Resection: Segmentectomy & Wedge Resection
For small early-stage tumors — particularly GGOs and part-solid nodules — sublobar resection (segmentectomy or wedge resection) may be oncologically equivalent to lobectomy while preserving more lung function. The landmark JCOG0802 trial confirmed that segmentectomy is non-inferior to lobectomy for tumors ≤2cm with a consolidation-to-tumor ratio (CTR) ≤0.5. Precise patient selection and surgical technique are critical to achieving optimal outcomes with sublobar resection.
Robotic-Assisted Thoracic Surgery (RATS)
Robotic-assisted thoracic surgery offers enhanced visualization and instrument precision for complex anatomical resections, particularly for centrally located tumors or those requiring complex segmentectomy. Robotic assistance is increasingly used at leading centers for technically demanding cases.
Adjuvant Therapy After Surgery
After curative resection, adjuvant therapy reduces recurrence risk:
- EGFR-mutant NSCLC (stage IB-IIIA) — osimertinib adjuvant therapy for 3 years (ADAURA trial)
- Stage II-IIIA NSCLC — adjuvant chemotherapy (cisplatin-based)
- PD-L1-positive stage IB-IIIA NSCLC — adjuvant atezolizumab or pembrolizumab
Active Surveillance for Indolent GGOs
Not all pulmonary nodules require immediate surgery. For pure GGOs and slowly growing part-solid nodules, active surveillance with serial CT imaging is appropriate — avoiding unnecessary surgery while monitoring for signs of progression that would indicate the need for resection. Expert judgment in distinguishing lesions that require surgery from those that can be safely observed is a hallmark of specialized early-stage lung cancer programs.
Why Choose Shanghai for Early-Stage Lung Cancer Surgery?
- National leadership in early-stage lung cancer surgery — Shanghai's leading thoracic surgeons are recognized as China's foremost experts in precision minimally invasive lung cancer resection
- High-volume specialized programs — extensive experience with GGOs, part-solid nodules, and complex segmentectomy
- Comprehensive molecular profiling — full genomic testing to guide adjuvant therapy selection after surgery
- Multidisciplinary integration — surgery coordinated with medical oncology and radiation oncology for optimal adjuvant treatment planning
- Cost-effective world-class care — significantly lower cost than equivalent treatment in the US, UK, or Singapore
Featured Specialist: Prof. Chen Haiquan — Fudan University Cancer Hospital
Prof. Chen Haiquan (陈海泉) is one of China's most distinguished thoracic surgeons and a nationally recognized leader in early-stage lung cancer minimally invasive surgery, based at Fudan University Shanghai Cancer Center (FUSCC) — China's premier dedicated cancer hospital.
National Leadership
Prof. Chen serves as Chairman of the Lung Cancer Committee of the Shanghai Anti-Cancer Association — the leading professional body for lung cancer specialists in Shanghai. This role reflects his standing as the foremost authority on lung cancer surgical treatment in the city.
Precision Minimally Invasive Surgery
Prof. Chen has built an outstanding reputation in the field of precision minimally invasive surgery for early-stage lung cancer — encompassing VATS lobectomy, anatomical segmentectomy, and the precise characterization and management of pulmonary nodules and GGOs. His expertise in identifying which lesions require surgery, which can be safely observed, and which surgical approach best balances oncological safety with lung function preservation is the defining feature of his clinical practice.
Clinical Expertise
- VATS lobectomy and segmentectomy — minimally invasive resection for early-stage lung cancer
- Pulmonary nodule and GGO management — precise characterization and individualized treatment planning
- Sublobar resection — lung-sparing surgery for small, indolent tumors
- Robotic-assisted thoracic surgery — for complex anatomical resections
- Adjuvant therapy planning — integrated with molecular profiling for optimal post-surgical treatment
For international patients, Prof. Chen's team offers remote pre-consultation review of CT scans, HRCT, PET-CT, and pathology, enabling a precise assessment of nodule characteristics and surgical planning to be developed before arrival in Shanghai.
How CMCS Supports Your Journey
CMCS is not a hospital — we are your dedicated medical concierge, providing a trusted bridge between international patients and Shanghai's finest cancer specialists.
Our services include:
- ✅ Direct appointment coordination with Prof. Chen Haiquan and the Fudan University Cancer Hospital thoracic surgery team
- ✅ CT, HRCT, PET-CT, and pathology translation and pre-consultation review
- ✅ Second opinion facilitation — especially for patients with pulmonary nodules or GGOs requiring expert assessment
- ✅ Hospital admission and surgical scheduling support
- ✅ Accommodation and logistics coordination in Shanghai
- ✅ Post-treatment follow-up and remote check-in support
Contact CMCS
If you or a loved one has been diagnosed with early-stage lung cancer or has a pulmonary nodule requiring expert assessment, our team is ready to help.
📧 Email: contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 Website: www.medicalsh.com
CMCS — China Medical Concierge Shanghai. Connecting international patients with Shanghai's finest specialists.
0 則留言